Skip to main content

Featured

Policy Address measures highlighted

Secretary for Commerce & Economic Development Edward Yau today briefed members of the Trade & Industry Advisory Board on initiatives related to commerce and trade in the 2021 Policy Address.   Mr Yau said the Policy Address focuses on integration into national development and states that the developments of Hong Kong and the nation are closely related.   While the nation is the major growth engine and driving force for the global economy, the 14th Five-Year Plan, the Outline Development Plan for the Guangdong-Hong Kong-Macao Greater Bay Area, the Qianhai plan, the economic development pattern of not only greater domestic circulation but also domestic and international dual circulation, as well as the Belt & Road Initiative have brought unlimited opportunities for enterprises and professional services providers in Hong Kong.   The city must seize these opportunities and leverage its advantages, Mr Yau noted.   During the meeting, the commerce chief stressed that Hong

Vaccine packaging issue probed

(To watch the full media session with sign language interpretation, click here.)   An investigation by BioNTech has revealed that packaging defects in its COVID-19 vaccine vials were caused by the crimping process and ultra-low storage temperature but did not affect the jabs' safety.   Director of Health Dr Constance Chan told a media session this afternoon that the Department of Health received a written notification from BioNTech today on its investigation into the packaging issue.   Dr Chan said: “Upon further investigation, samples (of the BioNTech vaccine vials with packaging defects) detected in Hong Kong were sent back to Germany for an investigation. They have done numerous tests and experiments on the vials concerned. They have also done tests in another fill and finish plant operated by Baxter.   “In the process, they found out that in the vials packed at the site which provided batches (numbered) 210102 and 210104, there were issues related to the so-called crimping process. Crimping is the process by which pressure is applied to the aluminium ring which affixes to the rubber stopper at the top of the vial.   “We received a report that the (defect in question) is related to the process of crimping and at the same time the condition of the ultra-low temperature of minus 70 degrees Celsius. So that is why BioNTech has now decided to send the new vials from Baxter which have undergone repeated experiments and investigations, and that would exclude further occurrence of such an event.”
http://dlvr.it/RwqJtL

Popular Posts